Status:
NOT_YET_RECRUITING
Hemodynamic Effects of Alpha Blockers in Patients With Spinal Anesthesia
Lead Sponsor:
Izmir City Hospital
Conditions:
Patient Group With Alpha Blocker Use
Eligibility:
All Genders
18+ years
Brief Summary
There is frequent use of alpha blockers in elderly patients with urological disorders. Various side effects are encountered due to the use of alpha blockers in the elderly age group. Especially hypote...
Detailed Description
Although α-1 adrenergic receptor blockers were initially developed for the treatment of hypertension, they have been widely used in the treatment of benign prostatic hyperplasia (BPH) over the last de...
Eligibility Criteria
Inclusion
- Patients with American Society of Anesthesiologists (ASA) physical status classification I,II or III over 18 years of age scheduled for elective urologic surgery under spinal anesthesia
Exclusion
- Patients not undergoing spinal anesthesia, non-alpha-blocker vasoactive drug users, patients with cardiac disease, medical/surgical history of brain or spinal cord, neurological or psychiatric disease
Key Trial Info
Start Date :
August 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06998537
Start Date
August 30 2025
End Date
October 30 2025
Last Update
August 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
İzmir City Hospital
Izmir, Bayraklı, Turkey (Türkiye), 35000